Activity

Filter

Cancel
Date Panel Item Activity
6 actions
Prepair 1000+ v0.93 SLC26A4 Zornitza Stark Marked gene: SLC26A4 as ready
Prepair 1000+ v0.93 SLC26A4 Zornitza Stark Gene: slc26a4 has been classified as Red List (Low Evidence).
Prepair 1000+ v0.93 SLC26A4 Zornitza Stark Classified gene: SLC26A4 as Red List (low evidence)
Prepair 1000+ v0.93 SLC26A4 Zornitza Stark Gene: slc26a4 has been classified as Red List (Low Evidence).
Prepair 1000+ v0.92 SLC26A4 Zornitza Stark reviewed gene: SLC26A4: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Deafness, autosomal recessive 4, with enlarged vestibular aqueduct (MIM#600791), Pendred syndrome (MIM#274600); Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal
Prepair 1000+ v0.85 SLC26A4 Crystle Lee gene: SLC26A4 was added
gene: SLC26A4 was added to Reproductive Carrier Screen_VCGS. Sources: Literature
Mode of inheritance for gene: SLC26A4 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: SLC26A4 were set to 24599119
Phenotypes for gene: SLC26A4 were set to Deafness, autosomal recessive 4, with enlarged vestibular aqueduct (MIM#600791); Pendred syndrome (MIM#274600)
Review for gene: SLC26A4 was set to AMBER
Added comment: PDS and NSEVA are considered a disease spectrum and are distinguishable based on the presence of thyroid dysfunction in PDS (GeneReviews).

In relation to severity of hearing, there's no correlation between missense vs PTCs. There was great variation in hearing loss severity with the same mutations. Phenotype cannot be predicted from the genotype (PMID: 24599119)
Sources: Literature